1. Home
  2. HCPCS Crosswalk
  3. HCPCS J3399

HCPCS J3399

Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes

Table of Contents

  1. HCPCS Information
  2. HCPCS Crossover to NDC Codes

HCPCS Information

HCPCS Code: J3399
The Healthcare Common Procedure Coding System (HCPCS) is a set of unique alphanumeric codes used to report medical procedures and services to healthcare programs like Medicare and Medicaid. HCPCS codes are used in conjunction with NDC codes for billing and medical documentation puporses. For instance, HCPCS J3399 identifies the type of service or supply used while any of the 22 NDC codes below could be used to specify the exact drug used.
Short Description
Inj onase abepar-xioi treat
Long Description
Injection, onasemnogene abeparvovec-xioi, per treatment, up to 5x10^15 vector genomes
Pricing Indicator
Drugs
Multiple Pricing Indicator
Not applicable as HCPCS priced under one methodology
Coverage Description
Carrier judgment
BETOS Type of Service
Other drugs
HCPCS Classification
List of HCPCS codes for: Drugs Administered Other Than Oral Method, Chemotherapy Drugs (J-codes)

HCPCS Crossover to NDC Codes

The NDC codes below allow precise billing based on the specific manufacturer and medication used:

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
71894-120Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-121Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-122Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-123Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-124Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-125Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-126Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-127Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-128Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-129Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-130Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-131Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-132Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-133Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-134Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-135Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-136Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-137Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-138Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-139Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-140Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE
71894-141Zolgensma Onasemnogene Abeparvovec-xioiKitNovartis Gene Therapies, Inc.ACTIVE